Stockscreener 앱 받기
1.41
0.00%
0.00
시간 외 거래:
1.41
전일 마감가:
$1.41
열려 있는:
$1.4
하루 거래량:
1.49M
Relative Volume:
0.41
시가총액:
$234.77M
수익:
-
순이익/손실:
$-111.13M
주가수익비율:
-1.0682
EPS:
-1.32
순현금흐름:
$-91.53M
1주 성능:
+0.71%
1개월 성능:
+2.17%
6개월 성능:
+161.11%
1년 성능:
-57.53%
1일 변동 폭
$1.36
$1.42
1주일 범위
$1.21
$1.42
52주 변동 폭
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.41 | 229.78M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Will Tenaya Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Why Tenaya Therapeutics Inc. stock is considered a top pick2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform - Seeking Alpha
Can Tenaya Therapeutics Inc. stock resist market sell offs2025 Top Gainers & High Conviction Investment Ideas - Newser
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Will Tenaya Therapeutics Inc. stock return to pre crisis levelsEarnings Overview Report & Safe Entry Point Identification - Newser
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga
Is Tenaya Therapeutics Inc. stock attractive for hedge fundsMarket Movers & Expert Approved Trade Ideas - BỘ NỘI VỤ
Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN
How geopolitical tensions affect Tenaya Therapeutics Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Will Tenaya Therapeutics (NASDAQ:TNYA) Spend Its Cash Wisely? - Yahoo Finance
How supply chain issues affect Tenaya Therapeutics Inc. stock - newser.com
How resilient is Tenaya Therapeutics Inc. stock in market downturnsIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.Breakout Watch & Safe Capital Investment Plans - newser.com
Tenaya Therapeutics SVP, finance Higa sells $1.8k in stock By Investing.com - Investing.com Australia
Tenaya therapeutics CEO Ali Faraz sells $4,157 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics SVP, finance Higa sells $1.8k in stock - Investing.com India
Tenaya therapeutics CMO Tingley sells $3826 in stock By Investing.com - Investing.com Canada
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Tenaya Therapeutics Inc. stock chart pattern explained2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Trend analysis for Tenaya Therapeutics Inc. this weekEarnings Risk Summary & Growth Focused Stock Reports - newser.com
Is Tenaya Therapeutics Inc. stock positioned well for digital economy2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Can Tenaya Therapeutics Inc. rally from current levelsJuly 2025 Patterns & Technical Confirmation Trade Alerts - newser.com
When is the best time to exit Tenaya Therapeutics Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Weekly Rundown: Tenaya Therapeutics' gene therapy for heart condition placed on hold - Drug Discovery News
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst CallSlideshow (NASDAQ:TNYA) 2025-11-14 - Seeking Alpha
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tenaya Therapeutics Inc 주식 (TNYA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Nov 17 '25 |
Sale |
1.33 |
2,877 |
3,826 |
169,926 |
| Ali Faraz | Chief Executive Officer |
Nov 17 '25 |
Sale |
1.33 |
3,126 |
4,158 |
299,666 |
| Higa Tomohiro | SVP, Finance |
Aug 18 '25 |
Sale |
1.25 |
2,962 |
3,711 |
95,338 |
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
1.44%
0.91%
자본화:
|
볼륨(24시간):